dc.creatorDemoro, Bruno
dc.creatorSarniguet, Cynthia
dc.creatorSánchez Delgado, Roberto
dc.creatorRossi, Miriam
dc.creatorLiebowitz, Daniel
dc.creatorCaruso, Francesco
dc.creatorOlea Azar, Claudio
dc.creatorMoreno, Virtudes
dc.creatorMedeiros, Andrea
dc.creatorComini, Marcelo A.
dc.creatorOtero, Lucía
dc.creatorGambino, Dinorah
dc.date.accessioned2012-05-30T20:30:19Z
dc.date.available2012-05-30T20:30:19Z
dc.date.created2012-05-30T20:30:19Z
dc.date.issued2012
dc.identifierDALTON TRANSACTIONS Volume: 41 Issue: 5 Pages: 1534-1543 Published: 2012
dc.identifierDOI: 10.1039/c1dt11519g
dc.identifierhttps://repositorio.uchile.cl/handle/2250/121652
dc.description.abstractIn the search for new therapeutic tools against neglected diseases produced by trypanosomatid parasites, and particularly against African Trypanosomiasis, whose etiological agent is Trypanosoma brucei, organoruthenium compounds with bioactive nitrofuran containing thiosemicarbazones (L) as co-ligands were obtained. Four ruthenium(II) complexes with the formula [Ru(2)(p-cymene)(2)(L)(2)]X(2), where X = Cl or PF(6), were synthesized and the crystal structures of two of them were solved by X-ray diffraction methods. Two of the complexes show significant in vitro growth inhibition activity against Trypanosoma brucei brucei and are highly selective towards trypanosomal cells with respect to mammalian cells (J774 murine macrophages). These promising results make the title organoruthenium compounds good lead candidates for further developments towards potential antitrypanosomal organometallic drugs.
dc.languageen
dc.publisherROYAL SOC CHEMISTRY
dc.subjectTRYPANOSOMA-CRUZI ACTIVITY
dc.titleNew organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución